|Bid||209.73 x 800|
|Ask||213.77 x 1100|
|Day's Range||207.90 - 213.60|
|52 Week Range||108.85 - 224.24|
|Beta (5Y Monthly)||0.28|
|PE Ratio (TTM)||44.98|
|Earnings Date||Jan 28, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||1.56 (0.74%)|
|Ex-Dividend Date||Nov 10, 2020|
|1y Target Est||189.80|
For his final "Executive Decision" segment of Mad Money Friday evening, Jim Cramer checked in Mick Farrell, CEO of ResMed , the medical device maker. ResMed made a huge pivot earlier in the year to aid in the fight against Covid-19. The company increased its ventilator production by 350%, Farrell said, making and distributing over 150,000 units around the globe.
QIAGEN (QGEN) aims to leverage its global reach and position in CDx and HPV testing by collaborating with BioNTech.
Zacks Industry Outlook Highlights: ResMed, Thermo Fisher Scientific, IDEXX Laboratories and STERIS